Telix Pharmaceuticals | TLX - Ebit

Preço das Ações
12.75
Mudança Diária
0.34 2.74%
Mensal
32.67%
Anual
-54.43%
Q1 Previsão
12.48




Ebit Alterar Data
Cochlear AUD 261.1M 13.9M 2025-12
CSL USD 2.64B 116M 2025-12
Integral Diagnostics AUD 24.99M 5.08M 2024-06
Mayne Pharma AUD -16.2M 13.2M 2024-06
Medical Developments International AUD -36K 12.96M 2025-12
Mesoblast USD -27.75M 14.36M 2025-12
Neuren Pharmaceuticals AUD 17.01M 154.09M 2025-12
Pacific Edge NZD -19.4M 2.91M 2025-12
Paradigm Biopharmaceuticals AUD -21.57M 11.26M 2025-12
Polynovo AUD 2.06M 1.18M 2025-12
PYC Therapeutics AUD -22.59M 3.25M 2025-12
Ramsay Health Care AUD 541.1M 20.7M 2025-12
ResMed USD 497.6M 35.25M 2025-12
Sonic Healthcare AUD 423.94M 80.3M 2024-12